Aptamers Engineered Nanocarriers for Cancer Therapy

Author:   Prashant Kesharwani, PhD (Assistant Professor, Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India) ,  Prashant Kesharwani (Assistant Professor, Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India)
Publisher:   Elsevier Science Publishing Co Inc
ISBN:  

9780323858816


Pages:   556
Publication Date:   28 September 2022
Format:   Paperback
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Our Price $673.20 Quantity:  
Add to Cart

Share |

Aptamers Engineered Nanocarriers for Cancer Therapy


Add your own review!

Overview

Full Product Details

Author:   Prashant Kesharwani, PhD (Assistant Professor, Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India) ,  Prashant Kesharwani (Assistant Professor, Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India)
Publisher:   Elsevier Science Publishing Co Inc
Imprint:   Woodhead Publishing
Weight:   1.000kg
ISBN:  

9780323858816


ISBN 10:   0323858813
Pages:   556
Publication Date:   28 September 2022
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Paperback
Publisher's Status:   Active
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Table of Contents

1. Cell-SELEX technology for aptamer selection 2. Biological characteristics of aptamers 3. Mechanisms of multi-drug resistance of cancer 4. Relevance of aptamers as targeting ligands for anticancer therapies 5. Aptamers as smart ligands for nano-carriers cancer targeting 6. Aptamer-functionalized liposomes for targeted cancer therapy 7. Aptamer-functionalized micelles for targeted cancer therapy 8. Aptamer-functionalized nanoparticles for targeted cancer therapy 9. Aptamer-functionalized PLGA nanoparticles for targeted cancer therapy 10. Aptamer-functionalized silica nanoparticles for targeted cancer therapy 11. Aptamer-functionalized gold nanoparticles for targeted cancer therapy 12. Aptamer-functionalized dendrimers for targeted cancer therapy 13. Aptamer-functionalized carbon nanotubes for targeted cancer therapy 14. Aptamer-functionalized quantum dots for targeted cancer therapy 15. Cancer immunotherapy via nucleic acid aptamers 16. Aptamer-based imaging and diagnostics for cancer cells 17. Microdevice-based aptamer sensors 18. Aptamer-based microfluidics for circulating tumor cells 19. Aptamer-based theranostic approaches for treatment of cancer 20. Challenges of aptamers as targeting ligands for anticancer therapies 21. Clinical use and future perspective of aptamers

Reviews

Author Information

Dr. Prashant Kesharwani is an assistant professor of pharmaceutics at School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India. He has more than 12 years of teaching, research, and industrial experience at international levels from various countries, including the United States, Malaysia, and India. An overarching goal of his current research is the development of nanoengineered drug delivery systems for various diseases. He has more than 300 international publications in well-reputed journals and more than 25 international books (Elsevier). He is a recipient of many research grants from various funding bodies. He is also the recipient of several internationally acclaimed awards, such as “USERN Laureate award”, most prestigious “Ramanujan Fellowship Award”. He actively participates in outreach and scientific dissemination for the service of the wider community.

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

MRG2025CC

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List